Laura Zeller/LinkedIn and Menno Germans/LinkedIn
Dec 20, 2025, 07:41
Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies
RPTH Journal shared a post on LinkedIn:
“In emergency neurosurgery, rapid DOAC reversal is critical. This systematic review evaluates perioperative outcomes of idarucizumab and andexanet alfa, highlighting evidence gaps and safety insights.
If you work in hemostasis, neurosurgery, or acute care, this one’s worth a look.
Senior Author: Menno Germans”
Title: Specific reversal agents for direct oral anticoagulants in neurosurgical emergencies – a systematic review
Authors: Laura Zeller, Jonas Rohr, Giovanna Brandi, Christoph Globas, Alexander Kaserer, Matthias Greutmann, Tilman Schubert, Jan-Dirk Studt, Katharina Geiling, Luca Regli, Menno R. Germans
Never miss hematology news with Hemostasis Today.
-
May 23, 2026, 08:15Alexander Krupp: Asundexian Receives Priority Review Designation from China‘s NMPA
-
May 23, 2026, 07:59Toward a Dedicated Framework for MIg-Driven Hemostatic Disorders – JTH
-
May 23, 2026, 07:53Ankit Panthari: Can Haemophilia Serve as A Health System Model for Other Rare Diseases in India?
-
May 23, 2026, 07:43Ted Roh: Indonesia’s Plasma Fractionation Plant Wins Social Infrastructure Deal of the Year at the IJGlobal Awards 2025
-
May 23, 2026, 07:36Angie Read: Stories of Strength and Resilience on The Latest Episode of Stroke Sisters
-
May 23, 2026, 07:30Ozlem Fidanci: Reflections From WHA79 on the Future of Stroke Care
-
May 23, 2026, 07:21Ney Carter Borges: Where the Benefit Appears in Dual Antiplatelet Therapy
-
May 23, 2026, 05:38SIUH Advances Precision Stroke Care with Vena MicroAngioscope – Northwell Health
-
May 23, 2026, 05:31Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia